FibroGen
Melissa Meteyry currently serves as a Drug Development Assistant at FibroGen, Inc., a position held since December 2013, where responsibilities include providing administrative support to an international research-based biotechnology team across multiple departments related to drug development. Prior experience spans various roles, including Executive Assistant at WCG World and office management positions at Wikia, Freeslate Inc., MarketBridge, Grey San Francisco, and Swiss Re Capital Partners. Melissa began the career in 1993 as a Reservationist at RunAway Tours, progressing through roles such as Office Manager and Receptionist. Educational background includes attendance at the University of California, Berkeley.
This person is not in the org chart
This person is not in any teams
FibroGen
FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, the Company's most advanced product candidate, is an oral small molecule inhibitor of HIF prolyl hydroxylase activity in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and is entering Phase III development for anemia in lower risk myelodysplastic syndromes (MDS). The Company has developed Pamrevlumab. Pamrevlumab is a proprietary therapeutic antibody to inhibit the activity of connective tissue growth factor (CTGF), a common factor in chronic fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure.